This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-preview: Archive
Unlocking Q2 Potential of Ecolab (ECL): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top-and-bottom-line estimates for Ecolab (ECL), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
ECLPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Gear Up for Booking Holdings (BKNG) Q2 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Booking Holdings (BKNG) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
BKNGPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Exploring Analyst Estimates for Royal Caribbean (RCL) Q2 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Royal Caribbean (RCL), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
RCLPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Stay Ahead of the Game With Phillips 66 (PSX) Q2 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Phillips 66 (PSX) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
PSXPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
What Analyst Projections for Key Metrics Reveal About Corning (GLW) Q2 Earnings
by Zacks Equity Research
Get a deeper insight into the potential performance of Corning (GLW) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
GLWPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Ares Capital (ARCC) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for Ares Capital (ARCC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
ARCCPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Stay Ahead of the Game With Johnson Controls (JCI) Q3 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Johnson Controls (JCI), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
JCIPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Ahead of Mondelez (MDLZ) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top-and-bottom-line estimates for Mondelez (MDLZ), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
MDLZPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Norfolk Southern (NSC) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
by Zacks Equity Research
Evaluate the expected performance of Norfolk Southern (NSC) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
NSCPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Exploring Analyst Estimates for Sysco (SYY) Q4 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Sysco (SYY), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
SYYPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Seeking Clues to Boeing (BA) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
by Zacks Equity Research
Besides Wall Street's top-and-bottom-line estimates for Boeing (BA), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
BAPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Gear Up for Visa (V) Q3 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top-and-bottom-line estimates for Visa (V), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
VPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
What Analyst Projections for Key Metrics Reveal About Commvault (CVLT) Q1 Earnings
by Zacks Equity Research
Evaluate the expected performance of Commvault (CVLT) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
CVLTPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Exploring Analyst Estimates for Merck (MRK) Q2 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for Merck (MRK), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
MRKPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Wall Street's Insights Into Key Metrics Ahead of UnitedHealth (UNH) Q2 Earnings
by Zacks Equity Research
Evaluate the expected performance of UnitedHealth (UNH) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
UNHPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Insights Into Astrazeneca (AZN) Q2: Wall Street Projections for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Astrazeneca (AZN) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
AZNPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
P&G (PG) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Evaluate the expected performance of P&G (PG) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
PGNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Paypal (PYPL) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for Paypal (PYPL), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
PYPLPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
CVS Q2 Estimates Dip: Is the Stock Still a Buy Ahead of Q2 Earnings?
by Urmimala Biswas
Earnings estimates for CVS dip ahead of Q2 results, but turnaround efforts in Aetna and PBM strength may offset pressure.
UNHPositive Net Change CVSNegative Net Change HLFPositive Net Change
earnings-estimates-revisions earnings-outlook earnings-preview earnings-report earnings-streak earnings-surprise healthcare medical medical-devices retail
Comfort Systems to Report Q2 Earnings: Buy, Sell or Hold the Stock?
by Shrabana Mukherjee
FIX heads into Q2 earnings with record backlog, resilient demand, and margin strength, but tough comps may slow its growth surge.
WSOPositive Net Change EMENegative Net Change AAONPositive Net Change FIXNegative Net Change
construction earnings-preview
CLS Stock Before Q2 Earnings: A Smart Buy or Risky Investment?
by Aritra Chatterjee
CLS eyes another earnings beat as AI demand and new product momentum drive strength in key growth segments.
JBLPositive Net Change CLSPositive Net Change SANMPositive Net Change
artificial-intelligence communications earnings-preview tech-stocks telecom
Tourmaline Oil Corp. (TRMLF) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Tourmaline Oil Corp. (TRMLF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TRMLFPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Wingstop (WING) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Wingstop (WING) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
WINGPositive Net Change CAKEPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Virtu Financial (VIRT) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Virtu Financial (VIRT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
VIRTPositive Net Change HLIPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
United Therapeutics (UTHR) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
United Therapeutics (UTHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UTHRPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate